ONMD

MINNEAPOLIS, Oct. 15, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced the addition of a leading hospital system to its iRWD™ platform and federated provider network and expects to expand the network by up to 12 additional hospitals. The new partnership meaningfully expands both the scale and more importantly clinical depth of OneMedNet’s healthcare data network. This expansion provides first party, direct-from-source delivering multimodal medical imaging, rich clinical reports, and associated heal

8-K - OneMedNet Corp (0001849380) (Filer)

4 - OneMedNet Corp (0001849380) (Issuer)

4 - OneMedNet Corp (0001849380) (Issuer)

4 - OneMedNet Corp (0001849380) (Issuer)

4 - OneMedNet Corp (0001849380) (Issuer)

MINNEAPOLIS, Sept. 30, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real World Data (RWD), today announced a seven figure multiyear agreement to deliver de-identified, multimodal, longitudinal clinical Real World Data to a commercially scaled AI-enabled precision medicine company. The data will be delivered to the customer through OneMedNet’s iRWD™ Platform. The customer intends to use the data to train AI-enabled clinical and diagnostic models and to create a licensable derivative dataset to sell into its own channel, linking the c

424B3 - OneMedNet Corp (0001849380) (Filer)

424B3 - OneMedNet Corp (0001849380) (Filer)

8-K - OneMedNet Corp (0001849380) (Filer)

MINNEAPOLIS, Sept. 25, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) (the "Company," "we," or "our"), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that it will implement a 1-for-10 reverse stock split of its issued and outstanding shares of common stock (the "Reverse Stock Split"), effective at 12:01 a.m. Eastern Time on September 29, 2026. The Reverse Stock Split was approved by the Company’s stockholders at its Annual Meeting of Stockholders held on September 18, 2026, with the final ratio, within the range approved by stockholders, subsequently determined by the Company’s board of direct

8-K - OneMedNet Corp (0001849380) (Filer)

Enhanced network coverage unlocks broader clinical insights and streamlined data access across healthcare, life sciences, and technology platforms Atropos Health, a leader in real-world evidence (RWE) generation from high-quality healthcare data, today announced a significant expansion of its federated Atropos Evidence™ Network. The expansion includes deeper collaborations with Norstella and Arcadia, along with new data partnership agreements with OneMedNet Corporation (NASDAQ:ONMD). These alliances extend the scope of Atropos Health’s data ecosystem across clinical decision support (CDS), model training, and benchmark development, delivering precision insights to power modern medicine.

MINNEAPOLIS, Sept. 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us," or "our"), a leading provider of regulatory decision-grade, AI-driven Real-World Data (RWD), today announced a strategic partnership with Atropos Health, the creator of real-world evidence for clinical decision-making under a multi-year agreement. The partnership adds OneMedNet's regulatory decision-grade data to Atropos’ platform and customer offerings under a fee arrangement adding to our Annual Recurring Revenue (ARR). The partnership embeds OneMedNet's data directly into Atropos Health's evidence-generation platform, giving Atropos customers access to more multi

MINNEAPOLIS, Sept. 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced year-to-date bookings of approximately $16.2 million, a 16X increase versus the same period in 2025. A significant portion of these bookings are expected to be delivered during the remainder of the year. Approximately 50% of the contracts booked during 2026 are with new customers to OneMedNet, while the existing customer base continues to expand their business with the Company through high rates of reorder and follow-on engagem

4 - OneMedNet Corp (0001849380) (Issuer)

MINNEAPOLIS, Aug. 31, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced a new agreement to deliver de-identified, full-fidelity clinical Real-World Data to a leading AI-driven drug development company. OneMedNet's iRWD™ Platform enabled cohort feasibility within minutes, data validation within a week, and signed contract within three weeks of initial contact, and is now delivering the data to support the customer's development and validation of AI models designed to accelerate and improve how new the

424B3 - OneMedNet Corp (0001849380) (Filer)

424B3 - OneMedNet Corp (0001849380) (Filer)

DEF 14A - OneMedNet Corp (0001849380) (Filer)

10-Q - OneMedNet Corp (0001849380) (Filer)

4 - OneMedNet Corp (0001849380) (Issuer)

PRE 14A - OneMedNet Corp (0001849380) (Filer)

MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-driven Real-World Data (RWD), today announced it has entered into an agreement to supply its regulatory-grade, multi-modal imaging-centric iRWD™ platform data for use in the development and training of a foundational AI model. Under the terms of the agreement, OneMedNet will provide high-quality, de-identified, regulatory-grade healthcare data, including millions of medical imaging and associated clinical reports, with data delivery immediately. The initial agreement has a total contract value in excess of

8-K - OneMedNet Corp (0001849380) (Filer)